873056-12-3 Usage
Uses
Used in Pharmaceutical Industry:
7-Amino-4,4-dimethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid tert-butyl ester is used as a key intermediate in the synthesis of new drugs for various therapeutic applications. Its unique structure and functional groups allow for the creation of molecules with improved pharmacological properties, such as increased potency, selectivity, and bioavailability.
Used in Agrochemical Industry:
In the agrochemical sector, 7-Amino-4,4-dimethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid tert-butyl ester is utilized as a building block for the development of novel pesticides. Its structural versatility enables the design of molecules with enhanced biological activity, leading to more effective and targeted pest control solutions.
Used in Medicinal Chemistry Research:
7-Amino-4,4-dimethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid tert-butyl ester is employed as a valuable research tool in medicinal chemistry. Its unique structure and functional groups make it an ideal candidate for exploring new chemical space and understanding the structure-activity relationships of potential drug candidates.
Used in Drug Discovery:
7-Amino-4,4-dimethyl-3,4dihydro-2H-quinoline-1-carboxylic acid tert-butyl ester plays a crucial role in drug discovery by serving as a key intermediate for the preparation of novel molecules with improved pharmacological properties. Its presence in the synthesis process allows researchers to optimize the therapeutic potential of new drug candidates, leading to the development of more effective treatments for various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 873056-12-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,3,0,5 and 6 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 873056-12:
(8*8)+(7*7)+(6*3)+(5*0)+(4*5)+(3*6)+(2*1)+(1*2)=173
173 % 10 = 3
So 873056-12-3 is a valid CAS Registry Number.
InChI:InChI=1/C16H24N2O2/c1-15(2,3)20-14(19)18-9-8-16(4,5)12-7-6-11(17)10-13(12)18/h6-7,10H,8-9,17H2,1-5H3
873056-12-3Relevant academic research and scientific papers
Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases
-
, (2015/09/22)
The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.
COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS AND OTHER CHRONIC DISEASES
-
, (2012/04/23)
The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.
